(Q50670506)

English

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO).

scientific article published in December 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

0 references

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). (English)

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

1 reference

based on heuristic

inferred from title

author name string

Gustafsson G

1

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Schmiegelow K

2

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Forestier E

3

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Clausen N

4

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Glomstein A

5

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Jonmundsson G

6

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Mellander L

7

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Mäkipernaa A

8

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Nygaard R

9

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Saarinen-Pihkala UM

10

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

publication date

1 December 2000

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

14

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

2267-2275

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

12

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

https://scigraph.springernature.com/pub.10.1038/sj.leu.2401961

0 references

Childhood leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Incidence, patient characteristics and treatment results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Non-Hodgkin's lymphoma in children.A progress report on the original patients treated with the LSA2-L2 protocol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

A population-based study of children with standard risk acute lymphoblastic leukemia in the five Nordic countries. A follow-up of 230 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate infusions in poor prognosis acute lymphoblastic leukemia: II. High-dose methotrexate (HDM) in acute lymphoblastic leukemia in childhood: a pilot study from April 1981

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic impact of karyotypic findings in childhood acute lymphoblastic leukaemia: a Nordic series comparing two treatment periods. For the Nordic Society of Paediatric Haematology and Oncology (NOPHO) Leukaemia Cytogenetic Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2401961

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2401961

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

release_mhpko3tbzvhxfcd5ebv35r4be4

1 reference

https://api.fatcat.wiki/v0/release/mhpko3tbzvhxfcd5ebv35r4be4

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

17 March 2018

http://europepmc.org/abstract/MED/11187918

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50670506&oldid=2062837386"